Dr Reddys Laboratories (RDY) Return on Sales (2009 - 2023)

Dr Reddys Laboratories (RDY) has reported Return on Sales for 15 consecutive years, with 0.0% the latest figure, recorded in Q2 2023.

• Quarterly Return on Sales changed N/A year-over-year to 0.0% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.0% (changed N/A YoY) and the FY2026 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.0% in Q2 2023 per RDY's latest filing, from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for RDY reached as high as 0.0% in Q1 2019 and fell as low as 0.0% in Q3 2020.
• A 5-year average of 0.0% and a median of 0.0% in 2020 frame the typical range for Return on Sales.
• The largest YoY upside for Return on Sales was 0 bps in 2019 against a maximum downside of 0 bps in 2019.
• Year by year, Return on Sales stood at 0.0% in 2019, then plunged by 244 bps to 0.0% in 2020, then jumped by 208 bps to 0.0% in 2021, then declined by 12 bps to 0.0% in 2022, then soared by 35 bps to 0.0% in 2023.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2023, Q1 2023, and Q4 2022 respectively.